Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

James Falko to Arteriosclerosis

This is a "connection" page, showing publications James Falko has written about Arteriosclerosis.

 
Connection Strength
 
 
 
0.138
 
  1. Falko JM, Parr JH, Simpson RN, Wynn V. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations. Am J Med. 1987 Oct; 83(4):641-7.
    View in: PubMed
    Score: 0.072
  2. Falko JM. High density lipoprotein (HDL): a protective lipoprotein. Ohio State Med J. 1980 Aug; 76(8):513-5.
    View in: PubMed
    Score: 0.044
  3. Falko JM, O'Dorisio TM, Cataland S. Improvement of high-density lipoprotein-cholesterol levels. Ambulatory type I diabetics treated with the subcutaneous insulin pump. JAMA. 1982 Jan 01; 247(1):37-9.
    View in: PubMed
    Score: 0.012
  4. Sundaram V, Hanna AN, Lubow GP, Koneru L, Falko JM, Sharma HM. Inhibition of low-density lipoprotein oxidation by oral herbal mixtures Maharishi Amrit Kalash-4 and Maharishi Amrit Kalash-5 in hyperlipidemic patients. Am J Med Sci. 1997 Nov; 314(5):303-10.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)